Clinical trial Recruiting at 1 site Interventional Ages 2 to 10

Vojta therapy to improve walking and mobility in children with Down syndrome

Official title: Effects of Vojta Therapy on Functional Mobility and Gait Parameter in Children With Down Syndrome

Run by Riphah International University · NCT07248267 · Data updated 2026-11-12

This trial will test whether an eight-week program of Vojta therapy can improve walking and overall mobility in children aged 2–10 with Down syndrome.

More Down Syndrome trials

Quick facts

Study typeInterventional
Ages2 Years to 10 Years
SexAll
Enrollment28 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Lahore, Punjab Province)
StatusRecruiting
StartedOctober 22, 2025
Main results expectedJanuary 30, 2026
Study endsJanuary 30, 2026
Registry record updatedNovember 25, 2025
Trial IDNCT07248267 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 2–10 with a confirmed diagnosis of Down syndrome who can stand and walk independently and whose parents provide informed consent are the ideal candidates.

Probably not a fit

Children with severe cardiac or other major medical conditions, recent orthopedic surgery, additional neurological disorders, serious behavioral issues, or current physical therapy are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will enroll 28 children with Down syndrome who can stand and walk independently and randomly assign them to either an experimental group receiving Vojta therapy or a control group for eight weeks. Functional mobility will be measured with the GMFM-88 and gait will be measured using spatial parameters such as step length, stride length, stride width, toe-in/toe-out, and base of support, with assessments at baseline and immediately after intervention. The intervention consists of repetitive sensorimotor Vojta exercises delivered over the eight-week period, and data will be analyzed using SPSS v27. The trial is conducted at Riphah International University’s Hashim center in Lahore, Pakistan.

Why it matters

Potential benefit: If successful, the therapy could improve step and stride length, walking stability, and daily mobility for young children with Down syndrome.

How similar studies have gone: Reflex locomotion (Vojta) has shown promising results in small studies in other pediatric motor disorders, but strong, specific evidence in children with Down syndrome is limited and this RCT is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age: 2-10 years old
* Confirmed diagnosis of Down syndrome by pediatric neurologist.
* Written informed consent obtained from parents or guardians.
* Independent standing and walking abilities assessed by GMFM dimension D and E.
* Functional hearing and vision, and understanding of instructions which were necessary for the measurement procedures
* No other physical therapy or interventions within the past three months

Exclusion Criteria:

* Presence of other significant medical conditions (e.g., severe cardiac issues).
* History of orthopedic surgery or significant musculoskeletal issues affecting mobility.
* Any additional neurological disorders that could confound results.
* Patient with Serious cognitive \& behavior issues that would interfere with group participation.
* Participation in other clinical trials during the study period

Where it's running

  • Hashim
    Lahore, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.